Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes

Diabetic Medicine

Volumn 29, Issue 2, 2012, Pages 272-277

  Secher, A L ^a,b   Madsen, A B ^a   Ringholm, L ^a   Barfred, C ^a   Stage, E ^a   Andersen, H U ^c   Damm, P ^a,b   Mathiesen, E R ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

Continuous glucose monitoring; Early pregnancy; Patient satisfaction; Pregestational diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; ISOPHANE INSULIN; LONG ACTING DRUG; SHORT ACTING INSULIN;

ADULT; ALARM MONITORING; ARTICLE; BLOOD GLUCOSE MONITORING; DISEASE DURATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUESTIONNAIRE; SELF REPORT; SEMI STRUCTURED QUESTIONNAIRE; SKIN IRRITATION; SLEEP;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; PATIENT SATISFACTION; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE; QUESTIONNAIRES;

EID: 84855802576     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03426.x     Document Type: Article

References (30)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1378-1383.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17-22.
3. Bode B, Beck RW, Xing D, Gilliam L, Hirsch I, Kollman C et al. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009; 32: 2047-2049.
4. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999; 46: 183-190.
5. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006; 29: 2730-2732.
6. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111: 933-938.
7. O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009; 52: 1250-1257.
8. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476.
9. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br Med J 2008; 337: a1680.
10. Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003; 101: 633-638.
11. McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007; 47: 186-190.
12. Secher AL, Schmidt S, Norgaard K, Mathiesen ER. Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancy. Acta Obstet Gynecol Scand 2010; 89: 1233-1237.
13. Worm D, Nielsen LR, Mathiesen ER, Norgaard K. Continuous glucose monitoring system with an alarm: a tool to reduce hypoglycemic episodes in pregnancy with diabetes. Diabetes Care 2006; 29: 2759-2760.
14. Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diagn 2006; 26: 123-127.
15. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006; 114: 63-67.
16. Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007; 30: 2785-2791.
17. Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011; 34: 406-411.
18. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the Guardian continuous monitoring system. Diabetes Technol Ther 2004; 6: 105-113.
19. Heckermann S, Nosek L, Zijlstra E, Heise T. Accuracy of a continuous glucose monitoring system (CGMS): still room for improvement. Diabetologia 2010; 53: 26-27.
20. Kerssen A, de Valk HW, Visser GH. The continuous glucose monitoring system during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technol Ther 2004; 6: 645-651.
21. Kerssen A, de Valk HW, Visser GH. Validation of the continuous glucose monitoring system (CGMS) by the use of two CGMS simultaneously in pregnant women with type 1 diabetes mellitus. Diabetes Technol Ther 2005; 7: 699-706.
22. 1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27: 1200-1201.
23. American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
24. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008; 31: 9-14.
25. Sorensen VR, Mathiesen ER, Watt T, Bjorner JB, Andersen MV, Feldt-Rasmussen B. Diabetic patients treated with dialysis: complications and quality of life. Diabetologia 2007; 50: 2254-2262.
26. Rubin RR, Peyrot M. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol 2009; 3: 1402-1410.
27. Peyrot M, Rubin RR. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technol Ther 2009; 11: 57-62.
28. Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009; 32: 1947-1953.
29. Ritholz MD, Atakov-Castillo A, Beste M, Beverly EA, Leighton A, Weinger K et al. Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med 2010; 27: 1060-1065.
30. 1c in insulin-treated diabetes (MITRE Study). Diabet Med 2009; 26: 540-547.